CLINICAL_TRIALS
trial_result
· 2013-06-13
Clinical Trial Update: Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease [Phase 2]
Summary
Phase 2 clinical trial evaluating Helicobacter pylori eradication in subjects with non-alcoholic fatty liver disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tehran University of Medical Sciences | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED